Greiner Bio-One North America, Inc. recently received their 3rd consecutive Novation contract through Novation’s public competitive bid process. This contract will extend the great working relationship between the organizations and benefit hospitals and patients.
Under this Novation Phlebotomy contract, the company will be able to continue supplying high quality blood and specimen collection products to hospitals and facilities. The contract for phlebotomy products began on February 1, 2015 and will continue for a 36 month term.
A leading manufacturer of a variety of products for the medical and research fields, Grenier Bio-One provides product manufacturing, distribution logistics, and product application support for clinical laboratories performing IVD testing, research laboratories in universities, startup companies, pharmaceutical and biotechnology corporations, and healthcare systems where patients’ blood specimens are taken, processed, transported, analyzed, and stored.
Director of Health Systems Brian Crowell said, "Being re-awarded the Novation Phlebotomy contract is a milestone in Greiner Bio-One’s history. We are excited to continue our relationship with Novation and the Members it serves and we look forward to the future".
A world market leader in the field of biotechnology, pharmaceuticals, clinical diagnostics, and research, Greiner Bio-One’s product range is comprehensive, and includes products for blood collection such as Winged Safety Blood Collection Sets with Luer Adapter, Vacuette Blood Culture Holder, VISIO PLUS Multi-sample Needle and VACUETTE® K3 EDTA Tube. The company also offers products for urine collection, plastic ware for the cultivation and analysis of cell and tissue cultures, microplates for high-throughput screening related to drug screening, and tests for the detection of bacteria and viruses. These blood collection systems, urine collection systems and specimen collection systems are used in more than 100 countries around the world.